Plant Health Care Share Discussion Threads

[wjccghcc] 07/4/2009 12:17

Except they've been promising explosive growth for the last couple of years and it's always been pushed back.

[nurdin] 07/4/2009 09:38

Amazing that people are selling these..explosive growth in earnings forecast for the coming years.

[nurdin] 06/4/2009 18:44

Steg...I might have something for you if youd like to leave me your email address ..

[nurdin] 06/4/2009 16:50

Hi steg...just completing my research on them.

Initial feedback is that Monasto were originally planning to use harpin on soya bean fields covering about 5-6m acres.The new deal now is for supply to cover almost 7-8m acres which is a huge jump.

PHC have to just sit back and collect royalties which I understand is about 4c per acre.On that basis PHC should record profits of almost $3.2m just for the current year.

The potential going forward is enormous with Monasto planning application over 60m acres within 5 year and over 100m acres over 6yrs.

Mouth watering !!

I will keep digging :o)

[stegrego] 03/4/2009 18:51

Nurdin, good to see you here.

I bought back into these today on the back of the late (and i think missed) Monsanto RNS.

Monsanto reported best ever results yesterday with outstanding numbers and growth.

Didnt buy that many as i want to see how they raise finance first before committing more.

If this goes correctly then its surely a bagger from here if the revenues start to flow.....

[nurdin] 03/4/2009 11:29

If harpin is such a success and they have other technologies to coomercialise,the market will be more than happy to support imo

[mdrans1] 03/4/2009 11:23

"In the light of this development, as well as other technology commercialisation opportunities, the Board is reviewing all financing alternatives to meet the Company's investment and working capital needs, so as to ensure future sales growth potential is realised."

No doubt it was sensible of them to trail this review of financing and put it in context so that there is no misinterpretation when they eventually make an announcement.

[nurdin] 03/4/2009 09:09

John Brady, CEO of Plant Health Care commented, "This order underlines
Monsanto's commitment to the rapid commercialisation of harpin. Plant Health
Care's strategy of commercialising its patented technologies with the world's
largest seed and agrichemical companies is now delivering for our shareholders
and, for the first time in our history, our natural technologies will be applied
by growers to millions of acres."

I cant say I disagree...:o)

[nurdin] 03/4/2009 08:32

..and the chart is turning too :o)

[nurdin] 03/4/2009 08:29

Anyone seen this?



Sneaked in after hours last night.Could be transformational...

[topgallant] 04/2/2009 09:10

Thanks AT useful article

[aim_trader] 03/2/2009 11:41

Tuesday, February 03, 2009
Plant Health Care:

Substantial revenue growth on the horizonCare. Plant Health Care undeniably has products with immense potential, but to maximise the potential, it needs a big company - or companies - to adopt its technology.
Full article ►

[mdrans1] 29/1/2009 12:32

Plant Health Care appears as a buy in today's Shares mag chemicals sector report.

[ceohunter] 06/1/2009 12:19

Plant Health investors may be interested in meeting Plant Impact?



The directors of Synchronica plc (AIM: SYNC), Plant Impact (AIM: PIM) and Medicsight (AIM: MDST) will be presenting:

Thursday the 15th January 2009
Chesterfield Mayfair Hotel, 35 Charles Street, Mayfair, W1J 5EB.

The presentations will start @ 6:00pm and finish at 7:30pm. After the presentations are complete the directors will also be available to take questions during a free canape and wine reception. Details on the presenting companies can be found at the above link.

Plant Impact (AIM:PIM)
Plant Impact specialises in plant stress relief. Plant Impact provide a dynamic and uncompromising new approach to crop nutrition and crop health, giving growers significantly increased marketable yields, more consistent quality with reduced environmental impact, leading to the ethically grown food demanded by consumers and the food chain.

[pugugly] 18/12/2008 12:22

duplicated

[pugugly] 18/12/2008 10:46

surely Myconate was seen as the lead product (in terms of ultimate cash flow) so the Bayer cancellation is very worrying to me. It suggests that Mayconate may have "problems".

Anyone much closer to the company/product area able to comment.

[mdchand] 18/12/2008 09:15

seems an over-reaction - monsanto is the deal maker here - not bayer.

[mdrans1] 18/12/2008 09:08

Termination of Myconate Collaboration Agreement with Bayer CropScience

"Plant Health Care is in agreement with this decision and believes this action is best for all parties."

Code for we can get a better deal ?

[mdrans1] 16/12/2008 15:54

Medium term too. From the news header:-

"Today's confirmation that Monsanto will deploy harpin in its
seed-coating product for soybeans, corn, cotton and certain vegetables gives
investors the long-term visibility they have been waiting for," says Philip
Sparks at Evolution Securities.
He estimates the deal could generate about 15 million pounds a year of
earnings in the medium term, and the U.S. sales of harpin as a seed coating
could be worth 450 pence per share on their own.

[r0ss] 16/12/2008 12:48

Excellent news for long term revenue!

[mdrans1] 19/6/2008 12:07

We get half a page in this weeks Shares Mag. cover feature :-

Food aid: The stock market solution

Including this from the house broker ;

"Philip Sparks at house broker Evolution Securities is bullish about the outlook for Plant Health Care, believing that 'the higher food prices go, the more cost-effective Plant Health Care's products become.' Plant Health Care also has the backing of Monsanto and Bayer, and Sparks believes that 'based on the Harpin roll-out projections from Monsanto and our Myconate forecasts for Bayer, Plant Health Care could conceivably deliver $40 million of annual earnings by 2012.' Sparks concludes that 'while 2007 was the year of validation for Plant Health Care, 2008 could be the year that soaring food prices boost the shares to record highs."

Plus half a page under Agenda market news and analysis , thumbs up from Al Gore no less. :-

Plant Health gets thumbs up
Published date: Thursday, June 19, 2008
Gore fund underscores green agro-chemical company's excellent prospects
by Timon Day
A fund run by former vice president and environmental campaigner Al Gore increased its stake in Plant Health Care to 5.3% last week and could go substantially higher.
Generation is an independent, private, owner managed partnership formed in 2004, based in London and co-founded by chairman Al Gore. Its new Climate Solutions Fund closed two months ago with $683 million to invest in small companies in four sectors: renewable energy, energy efficiency technologies, energy from biofuels and biomass, and the carbon trading markets.

[lasata] 12/6/2008 11:40

12 June 2006

Plant Health Care plc
("Plant Health Care" or "the Company")

OUTSTANDING YIELD GAINS IN WHEAT FOR MYCONATE

* Results of field trials in Mexico
* Significant sales of N-Hibit in South Africa

Plant Health Care (AIM: PHC), a leading provider of natural products for plants and soil,
is pleased to report the independent results
of its second significant grower field trials of Myconate with wheat in Mexico. The results
provide further compelling evidence of yield
stimulation in this crop.

These large scale trials conducted by local growers on areas varying from 3.4 to 6.25
hectares showed an average yield increase, over
the control, of 20% with a range of 8% to 31% increases. The Myconate was seed applied using
normal seed coating applications for Mexican
agriculture.

Importantly, the largest yield increases recorded were on fields that were treated with
Myconate in the trials a year prior, providing
evidence that the effect of Myconate is repeatable when used annually.

John Brady, Chief Executive of Plant Health Care commented: "These results are again
outstanding and provide further validation of the
benefits of Myconate technology for cereal grains, taking us another step closer to
commercialisation of the product".

Plant Health Care also announces a further advance with the launch of its Harpin based
N-Hibit product, which has been sold for grain
application onto some 40,000 acres of cereal in South Africa. This opens a new front for the
sale of Harpin which has traditionally been
linked to the corn, soya bean and cotton markets.

[cnx] 09/6/2008 01:48

some more encouraging announcements in last month

successful product development and commercial relationships
are the way to go